Association between NMD3 and symptoms of Parkinson's disease in Chinese patients.,BMC Neurology

当前位置： X-MOL 学术 › BMC Neurol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Association between NMD3 and symptoms of Parkinson's disease in Chinese patients.
BMC Neurology ( IF 2.2 ) Pub Date : 2020-01-14 , DOI: 10.1186/s12883-019-1574-1
Hui Wu ₁ , Hui Li ₁ , Zhiqiang Shi ₁ , Jiajia Tang ₁ , Shuya Mei ₁ , Tianyi Ai ₁ , Zhenzhou He ₁

Affiliation

BACKGROUND Parkinson's disease (PD) is a progressive neurodegenerative movement disorder that is characterized by motor symptoms such as tremor, rigidity, slowness of movement and problems with gait. Large-scale meta-analyses of genome-wide association studies (GWAS) have identified few susceptibility loci in patients with sporadic PD. The aim of this study was to investigate the association between NMD3 single nucleotide polymorphism (SNP) and symptoms in PD patients in South China. METHODS A total of 217 PD patients were recruited in this study and genotyped by using the SNaPshot technique and the polymerase chain reaction. All subjects were evaluated by the Mini-Mental State Examination (MMSE), Beijing version Montreal Cognitive Assessment (MoCA), Sniffin' Sticks 16 (SS-16), Hamilton Anxiety Rating Scale, Hamilton Depression Rating Scale, 39-item Parkinson's Disease Questionnaire (PDQ-39) and MDS Unified PD Rating Scale (MDS-UPDRS). RESULTS NMD3 rs34016896 (C > T) carriers have worse cognitive function than wild types (MMSE: p = 0.042, NMD3 wild type: 27.44 ± 2.89, NMD3 carriers: 26.31 ± 3.79; MoCA: p = 0.005, NMD3 wild type: 23.15 ± 4.20, NMD3 carriers: 20.75 ± 6.68). CONCLUSIONS The recessive and overdominant model of NMD3 rs34016896 was associated with cognitive impairment in PD patients.

更新日期：2020-01-14

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11